Agrx stock price target
Agile Therapeutics, Inc. Common Stock (AGRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. AGRX Agile Therapeutics — Stock Price and Discussion ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. ACRX | AcelRx Pharmaceuticals Inc. Analyst Estimates ... Nov 09, 2019 · AcelRx Pharmaceuticals Inc. analyst estimates by MarketWatch. View ACRX revenue estimates and earnings estimates, as well as analyst recommendations. AGRX Price Target - etfchannel.com The median AGRX price target (a different metric than the average or mean) was $ as of , the highest AGRX price target in the range was $ while the lowest AGRX price target in the range was $, with a standard deviation of $. Get the latest Zacks research report on AGRX — FREE. 10 ETFs With Most Upside To Analyst Targets
RBC Capital Keeps a Buy Rating on Agile Therapeutics (AGRX)
Researching Agile Therapeutics (NASDAQ:AGRX) stock? View AGRX's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Agile Therapeutics, Inc. (AGRX) Stock Price, Quote ... Find the latest Agile Therapeutics, Inc. (AGRX) stock quote, history, news and other vital information to help you with your stock trading and investing. The average price target comes in Agile Therapeutics, Inc. Common Stock (AGRX) Analyst ...
The 6 analysts offering 12-month price forecasts for Agile Therapeutics Inc have The current consensus among 6 polled investment analysts is to Buy stock in
Jan 23, 2020 · The one year price forecast for AGRX stock indicates that the average analyst price target is $4.4 per share. This means the stock has a potential increase of 50.68% from where the AGRX share price has been trading recently. During the recent trading session for Agile Therapeutics, Inc. (NASDAQ:AGRX), the company witnessed their stock rise $0 Why Shares of Agile Therapeutics, Inc. (AGRX) Plunged ... The one year price forecast for AGRX stock indicates that the average analyst price target is $4.4 per share. This means the stock has a potential increase of 18.6% from where the AGRX share price has been trading recently. During the recent trading session for Agile Therapeutics, Inc. (NASDAQ:AGRX), the company witnessed their stock drop by Agile Therapeutics Price Target Upside (Daily) | AGRX
Agile Therapeutics (AGRX) Stock Remains a Top Pick, Says Analyst. Marty Shtrubel March 23, Agile’s Strong Buy consensus rating breaks down into solely Buy ratings – 5, in fact. The average price target comes in identical to McCarthy’s, at $8.00. (See Agile stock analysis on TipRanks) Share this on WhatsApp. Tags: AGRX, NASDAQ, yahoo
AGRX - Agile Therap Stock Analyst Ratings - Barchart.com Analyst Ratings for Agile Therap (AGRX) provide recommendations made by outside industry experts. Barchart provides Analyst Ratings to give you another tool to gauge the possible future performance of a stock. Analyst Ratings are available for US and Canadian equities. Analyst Target Prices. The chart at the top shows a one-year chart Stock Comparison: Compare Agile Therapeutics, Inc. (AGRX ... Online Stock Comparison - Compare Agile Therapeutics, Inc. (AGRX) to four other stocks with NASDAQ.com's stock comparison tool.
The 6 analysts offering 12-month price forecasts for Agile Therapeutics Inc have The current consensus among 6 polled investment analysts is to Buy stock in
Agile Therapeutics, Inc. Common Stock (AGRX) Stock Quotes ... Agile Therapeutics, Inc. Common Stock (AGRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. AGRX Agile Therapeutics — Stock Price and Discussion ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. ACRX | AcelRx Pharmaceuticals Inc. Analyst Estimates ... Nov 09, 2019 · AcelRx Pharmaceuticals Inc. analyst estimates by MarketWatch. View ACRX revenue estimates and earnings estimates, as well as analyst recommendations.
Their average twelve-month price target is $6.20, suggesting that the stock has a possible upside of 228.04%. The high price target for AGRX is $9.00 and the Based on 5 analysts offering 12 month price targets for Agile Therapeutics in the last 3 months. The average price target is $7.80 with a high forecast of $9.00 The 6 analysts offering 12-month price forecasts for Agile Therapeutics Inc have The current consensus among 6 polled investment analysts is to Buy stock in Analyst price targets provided by TipRanks. Quick Links. Advanced Charting · After Hours Quote · Analyst Research